News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
706,198 Results
Type
Article (41865)
Company Profile (435)
Press Release (663898)
Section
Business (208522)
Career Advice (2016)
Deals (35978)
Drug Delivery (97)
Drug Development (83429)
Employer Resources (170)
FDA (16366)
Job Trends (15060)
News (352356)
Policy (33007)
Tag
Academia (2619)
Alliances (50806)
Alzheimer's disease (1343)
Approvals (16318)
Artificial intelligence (189)
Bankruptcy (363)
Best Places to Work (11820)
Biotechnology (329)
Breast cancer (216)
Cancer (1622)
Cardiovascular disease (131)
Career advice (1680)
CAR-T (115)
Cell therapy (339)
Clinical research (66801)
Collaboration (633)
Compensation (317)
COVID-19 (2614)
C-suite (146)
Data (1526)
Diabetes (197)
Diagnostics (6274)
Earnings (86322)
Employer resources (147)
Events (113956)
Executive appointments (524)
FDA (17185)
Funding (561)
Gene therapy (241)
GLP-1 (669)
Government (4431)
Healthcare (19070)
Infectious disease (2711)
Inflammatory bowel disease (121)
Interviews (309)
IPO (16690)
Job creations (3697)
Job search strategy (1431)
Layoffs (456)
Legal (7951)
Lung cancer (236)
Manufacturing (226)
Medical device (13389)
Medtech (13394)
Mergers & acquisitions (19571)
Metabolic disorders (539)
Neuroscience (1742)
NextGen: Class of 2025 (6747)
Non-profit (4542)
Northern California (1930)
Obesity (309)
Opinion (207)
Patents (138)
People (58064)
Phase I (20979)
Phase II (29484)
Phase III (21789)
Pipeline (639)
Postmarket research (2600)
Preclinical (8951)
Radiopharmaceuticals (256)
Rare diseases (315)
Real estate (6002)
Regulatory (22267)
Research institute (2406)
Resumes & cover letters (351)
Southern California (1681)
Startups (3753)
United States (17536)
Vaccines (601)
Weight loss (218)
Date
Today (103)
Last 7 days (600)
Last 30 days (2505)
Last 365 days (35865)
2025 (2475)
2024 (36299)
2023 (41015)
2022 (52276)
2021 (56763)
2020 (54923)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (213)
Asia (38830)
Australia (6460)
California (4474)
Canada (1601)
China (377)
Colorado (200)
Connecticut (220)
Europe (84670)
Florida (629)
Georgia (152)
Illinois (443)
Indiana (251)
Maryland (714)
Massachusetts (3496)
Michigan (190)
Minnesota (325)
New Jersey (1251)
New York (1268)
North Carolina (857)
Northern California (1930)
Ohio (160)
Pennsylvania (1026)
South America (1107)
Southern California (1681)
Texas (655)
Utah (127)
Washington State (449)
706,198 Results for "assertio therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors
December 18, 2024
·
4 min read
Press Releases
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - January 3, 2025
January 6, 2025
·
3 min read
BioMidwest
Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - June 06, 2024
Assertio Holdings, Inc. announced that effective May 31, 2024, the Compensation Committee of the Company’s Board of Directors granted the Company’s new Chief Executive Officer, Brendan P. O’Grady, 500,000 restricted stock units and 1,800,000 stock options.
June 6, 2024
·
3 min read
Business
Assertio Holdings, Inc. to Report First Quarter 2024 Financial Results on May 6, 2024
Assertio Holdings, Inc., a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that it will release first quarter 2024 financial results on Monday, May 6, 2024, after the market close.
April 25, 2024
·
1 min read
BioMidwest
Assertio to Participate in AGP Healthcare Conference on May 21
Assertio Holdings, Inc. today announced that Ajay Patel, Chief Financial Officer, will present at the Alliance Global Partners Virtual Healthcare Company Showcase to be held virtually on May 21, 2024.
May 16, 2024
·
3 min read
Business
Assertio Reports First Quarter 2024 Financial Results
Assertio Holdings, Inc., a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, reported financial results for the first quarter ended March 31, 2024.
May 6, 2024
·
20 min read
BioMidwest
Assertio to Participate in Benchmark Healthcare Conference on May 21-22
Assertio Holdings, Inc. announced that Ajay Patel, Chief Financial Officer, will host investor meetings as part of the Benchmark & Company Healthcare House Call Virtual Conference, taking place May 21-22, 2024.
May 17, 2024
·
2 min read
Press Releases
Assertio Announces Results of Rolvedon® (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study
December 13, 2024
·
4 min read
Business
Assertio Announces the Appointment of Brendan P. O’Grady as New CEO
Assertio Holdings, Inc. announced that its Board of Directors has appointed Brendan P. O’Grady, a highly accomplished pharmaceutical executive, as the Company’s new Chief Executive Officer and a member of the board, effective today, May 29, 2024.
May 29, 2024
·
4 min read
Business
Assertio Holdings, Inc. to Release Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
Assertio Holdings, Inc. announced that it will release fourth quarter and full year 2023 financial results on Monday, March 11, 2024, after the market close.
February 29, 2024
·
1 min read
1 of 70,620
Next
